BioAgilytix

BioAgilytix | October 07, 2016

BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has launched a new quality management software system, Quality Collaboration by Design (QCBD™), at its advanced laboratory facilities to further streamline management of key Quality Management Systems (QMS)....

BioAgilytix | July 08, 2016

BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, is expanding its U.S. headquarters in Durham, NC as well as its new European headquarters, IPM Biotech in Hamburg, Germany. BioAgilytix completed the acquisition of IPM Biotech in early 2016 and immediately set forth plans to build out a new advanced laboratory facility for its subsidiary, which will allow the company to expand IPM’s already robust platform suite to...

Labiotech.eu | January 28, 2020

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors can risk triggering the immune system to destroy them. This can lead to the therapy becoming ineffective....

FierceBiotech | January 27, 2020

Johnson & Johnson is joining the growing ranks of biopharmas, including the likes of Moderna and Gilead Sciences, in trying to create a speedy vaccine for the coronavirus out of China. Over the weekend, we learned of a wider range and more deaths as the new virus, which appears to have come out of Wuhan, China, is doing what these diseases do best: spread. The causes of death have so far been reported as pneumonia, with other reports suggesting most of these have come from those with underly...